Drugline is a fortnightly electronic drug bulletin for health professionals.


Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

New High-Strength Insulin

Drugline Volume 366

Humalog® U200, a double strength formulation of insulin lispro, has recently been added to the Pharmaceutical Benefits Scheme (PBS). This ultra-short-acting insulin is indicated for the management of type 1 and type 2 diabetes…

Read more

Tofacitinib Safety Issue

Drugline Volume 365

The Therapeutic Goods Administration (TGA) has issued a safety alert for tofacitinib following identification of an increased risk of pulmonary embolism and death in a post-marketing study. This safety signal was detected in a…

Read more

New Medication for Weight Management

Drugline Volume 364

Around 63% of Australian adults are overweight or obese, significantly increasing their risk of disease such as cardiovascular disease, type 2 diabetes, and some cancers. Contrave® is a new medication for weight management as…

Read more

Carbimazole Safety Issues

Drugline Volume 363

Carbimazole is an anti-thyroid medication indicated for the treatment of hyperthyroidism. Two safety issues have recently been highlighted following a review by the European Medicines Agency (EMA): Risk of pancreatitis; and The importance of…

Read more

Updated Recall Procedures

Drugline Volume 362

An updated version of the Uniform Recall Procedure for Therapeutic Goods (URPTG) has been introduced by the Therapeutic Goods Administration (TGA). Major changes to the URPTG that are now in effect include: The introduction…

Read more

Appropriate Use of Promethazine

Drugline Volume 361

Promethazine is a phenothiazine derivative with potent antihistaminic and sedative-hypnotic effects. The injectable form is currently registered for the treatment of uncomplicated allergic conditions of the immediate type; treatment and prevention of motion sickness,…

Read more
Load More

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012